The estimated Net Worth of Philip H Coelho is at least $3.53 Millón dollars as of 4 May 2023. Mr. Coelho owns over 50,000 units of Ampio Pharmaceuticals Inc stock worth over $451 and over the last 21 years he sold AMPE stock worth over $3,530,059. In addition, he makes $0 as Independent Director at Ampio Pharmaceuticals Inc.
Sign up
Mr. Coelho AMPE stock SEC Form 4 insiders trading
Philip has made over 54 trades of the Ampio Pharmaceuticals Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 50,000 units of AMPE stock worth $39,500 on 4 May 2023.
The largest trade he's ever made was exercising 350,000 units of Ampio Pharmaceuticals Inc stock on 2 December 2003 worth over $658,000. On average, Philip trades about 15,944 units every 72 days since 2003. As of 4 May 2023 he still owns at least 204,887 units of Ampio Pharmaceuticals Inc stock.
You can see the complete history of Mr. Coelho stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Philip Coelho biography
Philip H. Coelho M.D. serves as Independent Director of the Company. Mr. Coelho has served as a member of our Board since April 2010. Mr. Coelho is the Chief Technology Officer of ThermoGenesis Corp., a firm he founded in 1986 and retired from in 2007, which invents and commercializes products that isolate, purify and cryopreserve stem, progenitor and immune cells derived from a donor or the patient’s own body to treat human disease. Prior to rejoining ThermoGenesis Corp., Mr. Coelho founded SynGen Inc. in October 2009, and merged that company with ThermoGenesis Corp. in 2017. Mr. Coelho was the President and CEO of PHC Medical, Inc., a consulting firm, from August 2008 through October 2009. From August 2007 through May 2008, Mr. Coelho served as the Chief Technology Architect of ThermoGenesis Corp. From 1989 through July 2007, he was Chairman and CEO of ThermoGenesis Corp. Mr. Coelho served as Vice President of Research & Development of ThermoGenesis from 1986 through 1989. Mr. Coelho has been in the senior management of high technology consumer electronic or medical device companies for over 30 years. He was President of Castleton Inc. from 1982 to 1986, and President of ESS Inc. from 1971 to 1982. Mr. Coelho also serves as a member of the board of directors of NASDAQ-listed company, Catalyst Pharmaceuticals Partners, Inc. (CPRX) (since October 2002), and served as a member of the board of directors of NASDAQ-listed Mediware Information Systems, Inc. (MEDW) (from December 2001 until July 2006, and commencing again in May 2008 until it was sold in December 2012). Mr. Coelho received a B.S. degree in thermodynamic and mechanical engineering from the University of California, Davis and has been awarded more than 50 U.S. patents in the areas of cell cryopreservation, cryogenic robotics, cell selection, blood protein harvesting, and surgical homeostasis.
How old is Philip Coelho?
Philip Coelho is 75, he's been the Independent Director of Ampio Pharmaceuticals Inc since 2010. There are no older and 11 younger executives at Ampio Pharmaceuticals Inc.
What's Philip Coelho's mailing address?
Philip's mailing address filed with the SEC is 355 ALHAMBRA CIRCLE, SUITE 801, , CORAL GABLES, FL, 33134.
Insiders trading at Ampio Pharmaceuticals Inc
Over the last 14 years, insiders at Ampio Pharmaceuticals Inc have traded over $202,762 worth of Ampio Pharmaceuticals Inc stock and bought 377,748 units worth $116,063 . The most active insiders traders include Philip H Coelho, Joshua R. Disbrow y J Kevin Buchi. On average, Ampio Pharmaceuticals Inc executives and independent directors trade stock every 192 days with the average trade being worth of $74. The most recent stock trade was executed by J Kevin Buchi on 9 June 2023, trading 21,858 units of AMPE stock currently worth $6,339.
What does Ampio Pharmaceuticals Inc do?
ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.
What does Ampio Pharmaceuticals Inc's logo look like?
Complete history of Mr. Coelho stock trades at Catalyst Pharmaceuticals Inc y Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals Inc executives and stock owners
Ampio Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Michael E. Macaluso,
Founder, Chairman & CEO (Leave of Absence ) -
Daniel G. Stokely CPA, CPA,
CFO, Corp. Sec. & Treasurer -
Holli Cherevka,
Chief Operating Officer -
Daniel Stokely,
Chief Financial Officer, Treasurer, Secretary -
Michael Macaluso,
Chairman of the Board, Chief Executive Officer -
Holli Cherevka,
Pres & COO -
David Bar-Or,
Director -
David Stevens,
Independent Director -
Richard Giles,
Independent Director -
Philip Coelho,
Independent Director -
Laura Goldberg,
VP of Quality and Regulatory Operations -
April Ramirez,
Clinical Trial Mang. -
Lane Hapke,
VP of Manufacturing Operations -
Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.,
Chief Medical Officer -
Michael A. Martino,
CEO & Chairman -
Michael A Martino,
CEO -
J Kevin Buchi,
Director -
Vaughan Lennox Clift,
Chief Regulatory Affairs -
Gregory A Gould,
Chief Financial Officer -
Iii Thomas E. Chilcott,,
Chief Financial Officer -
Dan Stokely,
CFO -
Mark D Mc Gregor,
Chief Financial Officer -
Joshua R. Disbrow,
Chief Operating Officer -
Elizabeth Varki Jobes,